KRP-AM1977X PhaseIII Clinical Study-Double blind comparative study for the patients with community acquired pneumonia
Phase of Trial: Phase III
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Lascufloxacin (Primary) ; Levofloxacin
- Indications Community-acquired pneumonia
- Focus Registrational; Therapeutic Use
- Sponsors Kyorin Pharmaceutical
- 19 Apr 2017 Status changed from active, no longer recruiting to completed.
- 12 May 2016 Status changed from recruiting to active, no longer recruiting.
- 11 Mar 2016 New trial record